Related Experiment Videos
Genetic changes and histopathological grades in human hepatocellular carcinomas
M Konishi1, R Kikuchi-Yanoshita, K Tanaka
1Department of Biochemistry, Tokyo Metropolitan Institute of Medical Science.
Japanese Journal of Cancer Research : Gann
|August 1, 1993
Summary
Genetic alterations, including loss of heterozygosity (LOH) and p53 mutations, accumulate during liver cancer progression. These changes, particularly LOH on chromosomes 17p and 4q, are crucial in hepatocellular carcinoma (HCC) development.
Area of Science:
- Oncology
- Molecular Biology
- Hepatology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern, often linked to chronic hepatitis B (HBV) and C (HCV) virus infections.
- Understanding the genetic underpinnings of HCC progression is vital for developing targeted therapies and improving patient outcomes.
- Previous studies have implicated genetic alterations in liver cancer, but a comprehensive analysis across different differentiation grades is needed.
Purpose of the Study:
- To simultaneously analyze loss of heterozygosity (LOH) on eight chromosomes and p53 gene mutations in hepatocellular carcinomas (HCCs) of varying histopathological grades.
- To investigate the correlation between the accumulation of genetic changes and the progression of liver cancer.
- To compare the frequency of genetic alterations in HCCs from patients with HBV versus HCV exposure.
Main Methods:
- Sixty-three HCC samples were analyzed for LOH on chromosomes 1p, 4q, 5q, 8p, 13q, 16q, 17p, and 22q.
- p53 gene mutations were assessed using molecular techniques.
- Histopathological grading was performed to categorize tumors into well, moderately, and poorly differentiated groups.
Main Results:
- Frequencies of LOH and p53 mutations increased with advancing tumor grade, with poorly differentiated HCCs showing the highest rates.
- LOH on chromosomes 17p, 4q, and 8p, along with p53 mutations, were significantly more prevalent in advanced HCCs.
- LOH on chromosomes 17p and 4q appeared to precede other genetic alterations during liver cancer progression. HBV and HCV exposure showed comparable frequencies of genetic changes.
Conclusions:
- The accumulation of genetic changes in tumor suppressor genes, particularly LOH on 17p, 4q, 8p, and p53 mutations, plays a critical role in HCC progression.
- LOH on chromosomes 17p and 4q are early events in liver cancer development.
- Distinct p53 mutation patterns suggest different etiological agents for liver and colon cancers, and similar LOH mechanisms in HBV and HCV-infected patients.